关注
Christopher Alteri
Christopher Alteri
在 umich.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract
MC Lane, CJ Alteri, SN Smith, HLT Mobley
Proceedings of the National Academy of Sciences 104 (42), 16669-16674, 2007
4802007
Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle
CJ Alteri, SN Smith, HLT Mobley
PLoS pathogens 5 (5), e1000448, 2009
3332009
Mycobacterium tuberculosis produces pili during human infection
CJ Alteri, J Xicohténcatl-Cortes, S Hess, G Caballero-Olín, JA Girón, ...
Proceedings of the National Academy of Sciences 104 (12), 5145-5150, 2007
2542007
Mucosal immunization with iron receptor antigens protects against urinary tract infection
CJ Alteri, EC Hagan, KE Sivick, SN Smith, HLT Mobley
PLoS pathogens 5 (9), e1000586, 2009
2092009
Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments
CJ Alteri, HLT Mobley
Current opinion in microbiology 15 (1), 3-9, 2012
1862012
Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine
CJ Alteri, HLT Mobley
Infection and immunity 75 (6), 2679-2688, 2007
1552007
Multicellular bacteria deploy the type VI secretion system to preemptively strike neighboring cells
CJ Alteri, SD Himpsl, SR Pickens, JR Lindner, JS Zora, JE Miller, PD Arno, ...
PLoS pathogens 9 (9), e1003608, 2013
1432013
FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections
B Nesta, G Spraggon, C Alteri, DG Moriel, R Rosini, D Veggi, S Smith, ...
MBio 3 (2), e00010-12, 2012
1242012
Dietary l-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gut
S Kitamoto, CJ Alteri, M Rodrigues, H Nagao-Kitamoto, K Sugihara, ...
Nature microbiology 5 (1), 116-125, 2020
1192020
Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection
CJ Alteri, SD Himpsl, HLT Mobley
PLoS pathogens 11 (1), e1004601, 2015
1022015
Prophage induction is enhanced and required for renal disease and lethality in an EHEC mouse model
JS Tyler, K Beeri, JL Reynolds, CJ Alteri, KG Skinner, JH Friedman, ...
PLoS pathogens 9 (3), e1003236, 2013
952013
The Versatile Type VI Secretion System
CJ Alteri, HLT Mobley
Microbiology spectrum 4 (2), 2016
892016
The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli
CJ Alteri, JR Lindner, DJ Reiss, SN Smith, HLT Mobley
Molecular microbiology 82 (1), 145-163, 2011
872011
Metabolism and Fitness of Urinary Tract Pathogens.
CJ Alteri, HL Mobley
Microbiology spectrum 3 (3), 2015
862015
Development of a vaccine against Escherichia coli urinary tract infections
HLT Mobley, CJ Alteri
Pathogens 5 (1), 1, 2016
682016
SslE Elicits Functional Antibodies That Impair In Vitro Mucinase Activity and In Vivo Colonization by Both Intestinal and Extraintestinal Escherichia coli Strains
B Nesta, M Valeri, A Spagnuolo, R Rosini, M Mora, P Donato, CJ Alteri, ...
PLoS pathogens 10 (5), e1004124, 2014
662014
Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence
PD Vigil, CJ Alteri, HLT Mobley
Infection and immunity 79 (6), 2335-2344, 2011
602011
Optimization of an Experimental Vaccine to Prevent Escherichia coli Urinary Tract Infection
VS Forsyth, SD Himpsl, SN Smith, CA Sarkissian, LA Mike, JA Stocki, ...
mBio 11 (2), 2020
452020
Anaerobic respiration using a complete oxidative TCA cycle drives multicellular swarming in Proteus mirabilis
CJ Alteri, SD Himpsl, MD Engstrom, HLT Mobley
Mbio 3 (6), e00365-12, 2012
432012
Subtle variation within conserved effector operon gene products contributes to T6SS-mediated killing and immunity
CJ Alteri, SD Himpsl, K Zhu, HL Hershey, N Musili, JE Miller, HLT Mobley
PLoS pathogens 13 (11), e1006729, 2017
342017
系统目前无法执行此操作,请稍后再试。
文章 1–20